https://www.lumagroup.com 2026-03-19T15:06:39.915Z https://www.lumagroup.com/contact 2026-03-19T15:06:39.915Z https://www.lumagroup.com/insights 2026-03-19T15:06:39.915Z https://www.lumagroup.com/people 2026-03-19T15:06:39.915Z https://www.lumagroup.com/ 2026-02-26T18:10:50.000Z https://www.lumagroup.com/portfolio 2026-02-18T16:57:11.000Z https://www.lumagroup.com/privacy 2026-02-05T15:53:04.000Z https://www.lumagroup.com/terms 2026-02-05T15:53:33.000Z https://www.lumagroup.com/insights/decoding-aging-breakthroughs-challenges-and-the-future-of-longevity-drug-development 2026-03-19T13:23:26.000Z https://www.lumagroup.com/insights/from-blunt-sedation-to-precise-disease-control-insights-into-anti-seizure-medications 2026-03-18T20:57:48.000Z https://www.lumagroup.com/insights/delivering-on-the-promise-of-precision-medicine-our-investment-in-aeovian-pharmaceuticals 2026-03-18T21:20:43.000Z https://www.lumagroup.com/insights/god-bless-the-private-sector-how-private-funding-is-bridging-the-gap 2026-03-18T21:45:54.000Z https://www.lumagroup.com/insights/reimagining-chronic-care-a-conversation-with-ritish-patnaik-of-curve-biosciences 2026-02-24T17:36:00.000Z https://www.lumagroup.com/insights/ai-labi-and-how-we-invest-a-conversation-with-neel-madhukar-phd-and-themasap-khan-phd 2026-02-24T17:35:30.000Z https://www.lumagroup.com/insights/inside-the-golden-age-of-biotech-a-conversation-with-hans-bishop-of-altos-labs 2026-02-24T17:36:57.000Z https://www.lumagroup.com/insights/the-new-era-of-multi-omics-therapy-our-investment-in-character-bio 2026-02-19T13:50:05.000Z https://www.lumagroup.com/insights/the-case-for-venture-capital-in-biotechnology 2026-02-19T14:12:31.000Z https://www.lumagroup.com/insights/the-limits-of-generic-llms-why-biotech-needs-purpose-built-tools 2026-02-19T13:07:19.000Z https://www.lumagroup.com/insights/the-new-era-of-multi-omics-therapy-a-conversation-with-cheng-zhang 2026-02-24T17:36:24.000Z https://www.lumagroup.com/insights/drug-development-the-alchemy-of-hope 2026-02-19T18:34:03.000Z https://www.lumagroup.com/insights/from-hippocrates-to-hyperspeed-how-ai-will-catalyze-advancements-in-life-science 2026-02-19T14:15:00.000Z https://www.lumagroup.com/insights/the-next-frontier-in-chronic-disease-monitoring-our-investment-in-curve-biosciences 2026-02-19T13:50:45.000Z https://www.lumagroup.com/insights/unlocking-cures-the-path-from-concept-to-human-clinical-trials 2026-02-19T13:08:51.000Z https://www.lumagroup.com/insights/precision-therapy-applying-proven-technologies-to-inflammatory-and-immunological-disease-treatment 2026-02-19T14:11:13.000Z https://www.lumagroup.com/insights/illumanations-podcast-episode-1---dr.-rosana-kapeller-rome-therapeutics 2026-02-24T17:33:58.000Z https://www.lumagroup.com/insights/delivering-on-the-promise-of-precision-medicine-a-conversation-with-dr.-allison-hulme 2026-02-24T17:33:36.000Z https://www.lumagroup.com/insights/the-next-era-of-care-for-neurodegenerative-disease 2026-02-19T13:06:01.000Z https://www.lumagroup.com/insights/data-driven-biotechnology-how-multi-omics-analytics-are-shaping-the-future-of-medicine 2026-02-18T21:50:48.000Z